Read our Pleio Ponderings, case studies, news, white papers, blog posts, and webinars to gain insight on the industry.

April 2, 2026

In part two of his Pharmaceutical Commerce interview series, Pleio CEO Michael Oleksiw reframes pharma’s adherence problem as fundamentally human — not logistical. From the industry’s persistent “one-and-done” challenge to the underestimated role of loneliness in early discontinuation, Oleksiw makes the case that lasting behavior change requires meeting patients emotionally.

April 1, 2026

In his Pharma Live byline, Pleio CEO Michael Oleksiw puts empathetic AI to the test starting with a direct question to ChatGPT. The answer cuts to the heart of what the industry needs to hear: AI can simulate empathy, but it can’t feel it. In healthcare, where trust, emotional presence, and human judgment determine whether patients stay on therapy, that distinction isn’t semantic, it’s consequential.

PLEIO PONDERINGS & BLOG

Where emotion drives action through the written word.

Understanding Loneliness by Age

Discover how loneliness by age impacts patient needs—and why human connection still matters in a healthcare system dominated by digital tools.

WHITE PAPERS

Gain contextual, in-depth knowledge about a specific real-world subject.

The Hidden Enemies of Adherence: Mapping the Underminers Behind Every Missed Dose

Pleio analyzed over 140,000 real patient conversations through its AI-powered platform, OLLIE, to uncover what truly disrupts medication adherence. This analysis is based on the foundation of Pleio’s Barrier Blueprint, which organizes the complexity of adherence into seven dimensions, 37 drivers, and 85 distinct barriers

CASE STUDIES

Pleio reaches more patients with a human-first approach to adherence.

Patients diagnosed with a mental health condition requires heightened emotional support beyond traditional patient support programs.

WEBINARS / PODCAST

Learn and discover with our podcasts and webinars

AI Makes Healthcare More Human

On “The Tech Glow Up” live from HLTH 2025, Vital.io and Pleio share how AI can make healthcare more human—from translating medical jargon to uncovering emotional barriers that hinder adherence and patient trust.

WE PUT PRIVACY FIRST. GOODSTART® IS A FULLY TESTED, HIGHLY RELIABLE, TCPA, SOC 2 TYPE 2 CERTIFIED, AND HIPAA COMPLIANT MEDICATION SUPPORT PROGRAM.

Patient data is strictly used to support patients to take medications as prescribed by their healthcare professional.

CONTACT   |   PRIVACY   |   SUPPLIER CONDUCT   |  CAREERS



© 2025 Pleio, Inc All rights reserved.